Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC One Year Price Chart

<< Previous

Bullboard Posts

Next >>

Comment by Journeytcon Apr 30, 2024 10:15pm

184 Views

Post# 36016413

RE:RE:ONC One Year Price Chart

I believe major pharma are prohibited by an ONC NDA from putting in an offer to purchase. Why? If I was in the acquisition department a winning lottery ticket would be to find a company with century race horse....Pela......that had an insufferable management team incapable of getting anything across the finish line....ONC.....and with a stock price in the cellar. I can't think of a better opportunity than ONC. They could buy it for pocket change. So why haven't they?

<< Previous

Bullboard Posts

Next >>

AI companies to invest in